NCT02495246View on ClinicalTrials.gov

A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 21, 2015

Primary Completion Date

August 22, 2017

Study Completion Date

August 22, 2017

Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL

ChAd3-EBO-Z

BIOLOGICAL

Ad26.ZEBOV

Trial Locations (1)

OX3 7LE

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT02495246 - A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV | Biotech Hunter | Biotech Hunter